HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART).

Jessica M FogelEthan A WilsonEstelle Piwowar-ManningAutumn BreaudWilliam ClarkeChristos PetropoulosAyana MooreChristophe FraserBarry KosloffKwame Shanaube Gert U van ZylMichelle ScheepersSian FloydPeter Bock Helen M Ayles Sarah Fidler Richard J Hayes Deborah J Donnell Susan H Eshlemannull null

Published in: Journal of the International AIDS Society (2022)

UTT was not associated with an increase in drug resistance in this cohort. Higher rates of drug resistance and multi-class resistance were observed in non-seroconverters compared to seroconverters.

Keyphrases

antiretroviral therapy
hiv positive
human immunodeficiency virus
hiv infected
healthcare
hepatitis c virus
mental health
hiv aids
hiv testing
combination therapy
south africa